Measurement of platelet p-selectin expression by flow cytometry in patients with acute ischemic stroke

1. Smith N, Pathansali R, Bath P. Platelets and stroke. Vascular Medicine 1999; 4: 165–172.10.1177/1358836X9900400307Search in Google Scholar

2. Toghi H, Suzuki H, Tamura K, Kimura B. Platelet volume, aggregation, and adenosine triphosphate release in cerebral thrombosis. Stroke 1991; 22: 17–22.10.1161/01.STR.22.1.17Search in Google Scholar

3. Bath PM, Blann A, Smith N, Butterworth RJ. Von Willebrand factor, P-selectin and fibrinogen levels in patients with acute ischaemic and haemorrhagic stroke, and their relationship wit h stroke sub-type and functional outcome. Platelets 1998; 9, 155–159.10.1080/09537109876618Search in Google Scholar

4. Mohr JP, Sacco RL. Classification of ischemic strokes. Stroke: pathophysiology, diagnosis, and management 1992; vol. 2. 2nd ed. 271 – 83.Search in Google Scholar

5. Grau A, Ruf A, Vogt A, Lichy C, Buggle F, et al. Increased fraction of circulating activated platelets in acute and previous cerebrovascular ischemia. Thromb Haemost 1998; 80:298–301.10.1055/s-0037-1615191Search in Google Scholar

6. Marquardt L, Ruf A, Mansmann U, Winter R, Schuler M, Buggle F, Mayer H, Grau AJ. Course of platelet activation markers after ischemic stroke. Stroke 2002;33:2570–2574.10.1161/01.STR.0000034398.34938.20Search in Google Scholar

7. Mohamed Y, El-Senousy, Ehab A. El-Seidy, Mohamed K. Khalil, Hazem A. Fayed, et al. Platelet Activation Markers in Ischemic Cerebral Stroke. Egyptian Journal of Neurology, Psychiatry and Neurosurgery 2012; 49(2):109-115.Search in Google Scholar

8. Zeller JA, Tschoepe D, Kessler C. Circulating platelets show increased activation in patients with acute cerebral ischemia. Thromb Haemost 1999; 81: 373–377.10.1055/s-0037-1614480Search in Google Scholar

9. Tsai NW, Chang WN, Shaw CF, Jan CR, Chang HW, Huang CR, Chen SD, Chuang YC, Lee LH, Lu CH. Serial change in platelet activation markers with aspirin and clopidogrel after acute ischemic stroke. Clin Neuropharmacol. 2010 Jan-Feb;33(1):40-5.10.1097/WNF.0b013e3181b8abc6Search in Google Scholar

10 Kappelmayer J, Nagy B, Miszti-Blasius K, Hevessy Zs, Setiadi H. Review: The emerging value of P-selectin as a disease marker. Clin Chem Lab Med 2004;42(5):475–486.10.1515/CCLM.2004.082Search in Google Scholar

11. Bath PM, May J, Flaherty K, Woodhouse LJ. Remote Assessment of Platelet Function in Patients with Acute Stroke or Transient Ischaemic Attack. Stroke Research and Treatment 2017; Volume 2017, 13 pages.10.1155/2017/7365684Search in Google Scholar

12. Harrison P, Cramer EM. Platelet α-granules. Blood Rev 1993; 7: 2–62.10.1016/0268-960X(93)90024-XSearch in Google Scholar

13. Lee YJ, Jy W, Horstmann LL, Janania J, Reyes Y, et al. Elevated platelet microparticles in transient ischemic attacks, lacunar infarcts and multiple infarct dementias. Thromb Res 1993;72: 295–304.10.1016/0049-3848(93)90138-ESearch in Google Scholar

14. Michelson AD. Flow cytometry: a clinical test of platelet function. Blood 1996;87:4925 – 36.10.1182/blood.V87.12.4925.bloodjournal87124925Search in Google Scholar

15. Minamino T, Kitakaze M, Sanada S, Asanuma H, Kurotobi T, et al. Increased expression of P-selectin on platelets is a risk factor for silent cerebral infarction in patients with atrial fibrillation: role of nitric oxide. Circulation 1998;98:1721–27.10.1161/01.CIR.98.17.1721Search in Google Scholar

16. Shattil SJ, Cunningham M, Hoxie JA. Detection of activated platelets in whole blood using activation-dependent monoclonal antibodies and flow cytometry. Blood 1987;70:307 –10.1182/blood.V70.1.307.307Search in Google Scholar

17. Yamazaki M, Uchiyama S, Iwata M. Measurement of platelet fibrinogen binding and p-selectin expression by flow cytometry in patients with cerebral infarction. Thromb Res 2001; 104: 197–205.10.1016/S0049-3848(01)00350-4Search in Google Scholar

18. Nagy B, Debreceni IB, Kappelmayer J. Flow Cytometric Investigation of Classical and Alternative Platelet Activation Markers. The Journal of the International Federation of Clinical Chemistry and Laboratory Medicine 2013 Jan; 23(4): 124–134.Search in Google Scholar

19. Bath PM, May J, Heptinstall S. Clinical utility of remote platelet function measurement using P-selectin: assessment of aspirin, clopidogrel, and prasugrel and bleeding disorders. Platelets. 2018 Apr 18:1-6.10.1080/09537104.2018.1445839Search in Google Scholar

20. Chronos NAF, Wilson DJ, Janes SL, Hutton RA, Büller NP, Goodall AH. Aspirin does not affect the flow cytometric detection of fibrinogen binding to, or release of α-granules or lysosomes from, human platelets. Clin Sci 1994; 87: 575–580.10.1042/cs0870575Search in Google Scholar

21. Gralnick HR, Vail M, Williams S, McKeown L, Shafer B, Hansmann K. Platelet alpha granule release is not inhibited by aspirin and is mediated by myosin light chain kinase and protein C kinase. Blood 1990; 75: 128–38.Search in Google Scholar

22. Dovlatova N, Heptinstall S, May J, Bath P. Remote platelet function testing using platelet p-selectin as a marker of platelet activation. Findings in patients with stroke or tia treated with clopidogrel. Res Pract Thromb Haemostasis.2017;1:S1.Search in Google Scholar

23. Fox SC, May JA, Johnson A, et al. Effects on platelet function of an EP3 receptor antagonist used alone and in combination with a P2Y₁₂ antagonist both in-vitro and ex-vivo in human volunteers. Platelets. 2013;24(5):392-400.10.3109/09537104.2012.704648Search in Google Scholar

24. Fox SC, May JA, Dovlatova N, Glenn JR, Johnson A, White AE, Radhakrishnan A, Heptinstall S. How does measurement of platelet p-selectin compare with other methods of measuring platelet function as a means of determining the effectiveness of antiplatelet therapy? Platelets. 2018;1–610.1080/09537104.2018.1434311Search in Google Scholar

25. Bath PM, Woodhouse LJ, Appleton JP, Beridze M, Christensen H, Dineen RA, Duley L, England TJ, Flaherty K, Havard D, et al. Intensive versus guideline antiplatelet therapy in patients with acute cerebral ischaemia (tardis): a randomised, open-label, phase iii, superiority trial. Lancet. 2018;391:850859.10.1016/S0140-6736(17)32849-0Search in Google Scholar

26. TARDIS Trial Investigators, Krishnan K, Beridze M, Christensen H, Dineen R, Duley L, Heptinstall S, James M, Markus H, Pocock S, et al. Safety and efficacy of intensive vs. Guideline antiplatelet therapy in high-risk patients with recent ischemic stroke or transient ischemic attack: rationale and design of the triple antiplatelets for reducing dependency after ischaemic stroke (tardis) trial(isrctn47823388). Int J Stroke. 2015;10:1159–1165.10.1111/ijs.12538485564326079743Search in Google Scholar

27. Heptinstall S, Dovlatova N, May J, Robson K, Bath P. Remote platelet function testing using measurements of p-selectin in patients with acute stroke or tia already receiving treatment with antiplatelet agents. J Thromb Haemostasis. 2015;13:695.Search in Google Scholar

28. Heptinstall S. Remote platelet function testing using platelet-bound p-selectin as a marker of platelet activation. Res Pract Thromb Haemost.2017;1:S1Search in Google Scholar

29. Thomas MR, Wijeyeratne YD, May JA, Johnson A, Heptinstall S, Fox SC. A platelet P-selectin test predicts adverse cardiovascular events in patients with acute coronary syndromes treated with aspirin and clopidogrel. Platelets 2014;25:612–618.10.3109/09537104.2013.86385824433232Search in Google Scholar

30. Johnston GI, Pickett EB, McEver RP, George JN. Heterogeneity of platelet secretion in response to thrombin demonstrated by flow cytometry. Blood 1987;69:1401–3.10.1182/blood.V69.5.1401.1401Search in Google Scholar

31. Algahtani M, Heptinstall S. Novel strategies for assessing platelet reactivity. Future Cardiol. 2017 Jan;13(1):33-47.10.2217/fca-2016-005427990840Search in Google Scholar

32. Rinder HM, Murphy M, Mitchell JG, Stocks J, Ault KA, Hillman RS. Progressive platelet activation with storage:evidence for shortened survival of activated platelets after transfusion. Transfusion 1991;31:409–14.10.1046/j.1537-2995.1991.31591263195.x1710840Search in Google Scholar

33. Sirolli V, Ballone E, Garofalo D, Merciaro G, Settefrati N, Di Mascio R, et al. Platelet activation markers in patients with nephrotic syndrome. A comparative study of different platelet function tests. Nephron 2002;91:424–30.10.1159/00006428212119472Search in Google Scholar

34. Berger G, Hartwell DW, Wagner DD. P-selectin and platelet clearance. Blood 1998;92:4446–52.10.1182/blood.V92.11.4446Search in Google Scholar

35. Michelson AD, Bernard MR, Hechtman HB, MacGragor H, Connolly RJ, Loscalzol J, et al. In vivo tracking of platelets: circulating degranulated platelets rapidly lose surface P-selectin but continue to circulate and function. Proc Natl Acad Sci USA 1996;93:11 877–82.10.1073/pnas.93.21.11877381528876231Search in Google Scholar